RT @ericdeinmd: IL-6 for PMR SPARE and SEMAPORE (Toci), SAPHYR (Sari) 2/2023: FDA approves sarilumab for PMR for inadequ

Mar 18, 2023 2:54 pm
Social Author Image
https://pbs.twimg.com/profile_images/1322922848810422289/oM4qP9_k.jpg
Tweet Author
ericdeinmd
Social Author Name
Eric Dein
Tweet Content
IL-6 for PMR SPARE and SEMAPORE (Toci), SAPHYR (Sari) 2/2023: FDA approves sarilumab for PMR for inadequate response to corticosteroids or unable to taper off Robert Spiera @RheumNow #RNL2023 https://t.co/quOWjJjgB3
Show on Archive Page
On
Display in Search Results
On
PDQ
Off

    Do you get our email newsletter?

    Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

    Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

    Copyright 2023 All Rights Reserved.

    ×